Clinical Trials Browser

AGN 194204 × Clear all

NCT01540071 2021-05-14

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Phase 2 Completed

38 enrolled 11 charts

Castration Resistant Prostate Cancer

NCT00630760 2014-05-21

Oral NRX 194204 in Patients With Refractory Malignancies

Phase 1 Terminated

Neoplasms

NCT00964132 2009-09-03

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms